Urinary growth hormone excretion in preterm neonates

Area of Science:

• Neonatology
• Pediatric Nephrology
• Biochemistry

Background:

• Preterm neonates exhibit unique physiological challenges.
• Assessing organ function in sick neonates is crucial for management.
• Growth hormone and renal markers require specific interpretation in this population.

Purpose of the Study:

• To investigate urinary growth hormone (U-GH) and beta-2 microglobulin (U-B2) in preterm neonates.
• To correlate U-GH and U-B2 with serum growth hormone (S-GH) and clinical status.
• To determine the clinical significance of U-GH in preterm infants.

Main Methods:

• Measurement of U-GH, U-B2, and S-GH at multiple time points (days 1, 4, 7, 14, 28).
• Inclusion of preterm neonates with varying degrees of prematurity and illness.
• Statistical analysis to assess correlations between biomarkers and clinical parameters.

Main Results:

• U-GH and U-B2 levels were elevated in preterm neonates, particularly in sicker infants with respiratory failure requiring mechanical ventilation.
• U-GH showed significant positive correlations with U-B2 throughout the study.
• U-GH correlated with S-GH only on day 7.

Conclusions:

• In preterm neonates, U-GH primarily reflects renal proximal tubular function.
• Renal tubular function is influenced by the degree of renal maturation and disease-related tubular injury.
• U-GH serves as a potential indicator of renal health in vulnerable preterm infants.